Come up with a name for your new list and we'll add to it:
PersonalizeDx was acquired by
Rosetta Genomics on April 09, 2015.
PersonalizeDx performs clinically proven molecular tests that can aid in the detection and identification of certain cancers. PersonalizeDx intends to inform and educate both physicians and their pati…